A compound with the SMILES Cc1ccc(Cn2c(C3CCCN3c3nc(-c4cc(Cl)c(N)c(Cl)c4)cs3)nc3cc(C(=O)NCCCO)ccc32)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 12.154%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1ccc(Cn2c(C3CCCN3c3nc(-c4cc(Cl)c(N)c(Cl)c4)cs3)nc3cc(C(=O)NCCCO)ccc32)cc1
Cc1ccc(Cn2c(C3CCCN3c3nc(-c4cc(Cl)c(N)c(Cl)c4)cs3)nc3cc(C(=O)NCCCO)ccc32)cc1
2-[1-[4-(4-amino-3,5-dichlorophenyl)-1,3-thiazol-2-yl]pyrrolidin-2-yl]-N-(3-hydroxypropyl)-1-[(4-methylphenyl)methyl]benzimidazole-5-carboxamide